A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic

被引:60
作者
Goode, Kevin M. [1 ]
Nabb, Samantha [1 ]
Cleland, John G. F. [1 ]
Clark, Andrew L. [1 ]
机构
[1] Castle Hill Hosp, Hull Royal Infirm, Dept Cardiol, Kingston Upon Hull HU3 2JZ, Yorks, England
关键词
heart failure; prognosis; symptom score;
D O I
10.1016/j.cardfail.2008.01.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The New York Heart Association (NYHA) classification is recommended for grading symptoms of chronic heart failure and is a powerful prognostic marker. Patient-rated NYHA (Pa-NYHA) and physician-rated NYHA (Dr-NYHA) class have never been compared directly, and it is unknown whether they carry similar prognostic significance. Methods and Results: NYHA class was rated independently by a physician and patient in 1752 patients referred with suspected heart failure. Pa-NYHA and Dr-NYHA varied by 1 class in 37.1% cases and by 2 classes in 12.8% cases. Mean Dr-NYHA and Pa-NYHA were higher in women than men (1.98 vs 1.89, P = .016; 2.17 vs 2.02, P = .002) despite less cardiac disease. Dr-NYHA correlated more with 6-minute walk test distance and severity of left ventricular systolic dysfunction than Pa-NYHA (Spearman's rho: -0.53 vs -0.44 and 0.32 vs 0.16). Dr-NYHA better predicted mortality when compared with Pa-NYHA (log-rank: chi(2) = 105 vs 46, both P < .001). Conclusion: Patients rate NYHA differently from physicians, and women rate NYHA differently from men. Dr-NYHA relates more strongly to survival and severity of left ventricular systolic dysfunction, suggesting that for physicians the NYHA classification may have become a "heart failure severity score" and not as was intended, purely a measure of a patient's symptoms and functional status.
引用
收藏
页码:379 / 387
页数:9
相关论文
共 45 条
[1]   The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function [J].
Abdulla, J ;
Burchardt, H ;
Abildstrom, SZ ;
Kober, L ;
Torp-Pedersen, C .
EUROPEAN HEART JOURNAL, 2003, 24 (23) :2116-2122
[2]   Executive summary:: HFSA 2006 comprehensive heart failure practice guideline [J].
Adams, KF ;
Lindenfeld, J ;
Arnold, JMO ;
Baker, DW ;
Barnard, DH ;
Baughman, KL ;
Boehmer, JP ;
Deedwania, P ;
Dunbar, SB ;
Elkayam, U ;
Gheorghiade, M ;
Howlett, JG ;
Konstam, MA ;
Kronenberg, MW ;
Massie, BM ;
Mehra, MR ;
Miller, AB ;
Moser, DK ;
Patterson, JH ;
Rodeheffer, RJ ;
Sackner-Bernstein, J ;
Silver, MA ;
Starling, RC ;
Stevenson, LW ;
Wagoner, LE ;
Francis, GS ;
Bristow, MR ;
Cohn, JN ;
Colucci, WS ;
Greenberg, BH ;
Force, T ;
Krumholz, HM ;
Liu, PP ;
Mann, DL ;
Piña, IL ;
Pressler, SJ ;
Sabbah, HN ;
Yancy, CW .
JOURNAL OF CARDIAC FAILURE, 2006, 12 (01) :10-38
[3]  
[Anonymous], 1994, NOMENCLATURE CRITERI
[4]   Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy [J].
Bart, BA ;
Shaw, LK ;
McCants, CB ;
Fortin, DF ;
Lee, KL ;
Califf, RM ;
OConnor, CM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (04) :1002-1008
[5]   Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease [J].
Bennett, JA ;
Riegel, B ;
Bittner, V ;
Nichols, J .
HEART & LUNG, 2002, 31 (04) :262-270
[6]   Predictors of prognosis in patients with stable mild to moderate heart failure [J].
Bettencourt, P ;
Ferreira, A ;
Dias, P ;
Pimenta, J ;
Frioes, F ;
Martins, L ;
Cerqueira-Gomes, M .
JOURNAL OF CARDIAC FAILURE, 2000, 6 (04) :306-313
[7]  
Böhm M, 2003, Z KARDIOL, V92, P668, DOI 10.1007/s00392-003-0959-7
[8]   Management of elderly patients with congestive heart failure - Design of the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) [J].
Brunner-La Rocca, Hans Peter ;
Buser, Peter Theo ;
Schindler, Ruth ;
Bernheim, Alain ;
Rickenbacher, Peter ;
Pfisterer, Matthias .
AMERICAN HEART JOURNAL, 2006, 151 (05) :949-955
[9]   A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET) [J].
Cleland, JGF ;
Goode, K ;
Erhardt, L ;
Remme, WJ ;
Charlesworth, A ;
Poole-Wilson, PA ;
Di Lenarda, A ;
Hanrath, P ;
Komajda, M ;
Metra, M ;
Swedberg, K ;
Trop-Pedersen, C .
CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (02) :139-152
[10]   Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey [J].
Cleland, JGF ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Eastaugh, J ;
Follath, F ;
Freemantle, N ;
Gavazzi, A ;
van Gilst, WH ;
Hobbs, FDR ;
Korewicki, J ;
Madeira, HC ;
Preda, I ;
Swedberg, K ;
Widimsky, J .
LANCET, 2002, 360 (9346) :1631-1639